loader2
Partner With Us NRI

Company details

155.00
159.10
98.00
249.40
6M Return 0.00%
1Y Return 50.95%
Mkt Cap.(Cr) 167.26
Volume 17,600
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 17,600

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 9.77 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 26,236.77 -40,596.65
LAST 3M 79,235.45 -51,582.04
LAST 6M 145,414.64 -203,666.72
LAST 12M 206,629.88 -176,261.45
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
48.21
66.34%
34.131
16.57%
17.23%
Description
  • Vaidya Sane Ayurved Laboratories Ltd was originally incorporated as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by Registrar of Companies, Pune dated April 6, 1999 with name Vaidya Sane Ayurved Laboratories Private Limited. Subsequently, the Company was converted into a public limited company and the name of Company was changed to A?Vaidya Sane Ayurved Laboratories Limited by a special resolution passed on November 19, 2021. A fresh Certificate of Incorporation consequent upon conversion was issued on November 25, 2021 by the Registrar of Companies, Pune. The company was listed on National Stock Exchange since 23 February 2022. The company is involved in research and experimental development on natural sciences and engineering. Speciality chain Of Cardiac Clinics `Vaidya Sane Ayurved Laboratories Ltd` is a unique medical service institution popularly known as `Madhavbaug` that treats chronic ailments like cardiac disease, diabetes, hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda practices. Madhavbaug has approach to treatment in using non-invasive, multidisciplinary and innovative therapies for treating chronic ailments. The company mainly offers treatment for heart disease, diabetes reversal, blood pressure, Obesity management and knee pain relief camp services. Presently, the company operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh. Out of these 52 are company-owned and 222 are franchise clinics. Moreover, it operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively. It offers several wellness products through their online portal Madhavbaug Wellness, subject to an online app called MIB Pulse App which helps heart patients. Madhavbaug treatments rely on advanced therapies with systematic non-surgical approach to relieve patients of heart disease and risk factors or conditions that cause heart disease. Their treatments are scientifically researched integration of Ayurveda and modern medical science. Madhavbaug`s ApexBeat programs allow specialists to use technology in recommending specialized diets, physiotherapy, and lifestyle modifications in patients to offset the risk of heart disease. The main focus is controlling risk factors of heart disease and preventing its further progression into full blown heart disease. The company`s heart disease reversal programs cover treatments for patients with all stages of heart disease and even previously undiagnosed patients with high risk of developing heart disease.The treatments are target driven and help improve the VO2max levels and MET value of patients which results in an increased exercise tolerance, reduced risk of chronic heart failure or heart attack, and improved quality of life. It has a strong track record of patients who have obtained relief from life threatening diseases with upcoming treatments. Madhavbaug`s non-invasive heart treatments are designed to prevent and treat complex heart disease at different stages of the disease. These evidence-based researched treatments help patients in not only healing their condition, but also strengthens heart and improve quality of life. Its diabetes management program is based on a combination of proven Ayurvedic therapies, yoga, and lifestyle modifications. Customized exercises also help to reduce fat accumulation on liver which reduces insulin resistance and stabilizes blood sugar levels, while Ayurvedic and yoga treatments support the insulin production and reduce insulin resistance. Madhavbaug`s programs for diabetes has helped reverse diabetes symptoms for several patients who enjoy a full and healthy life today. In 2006, First Cardiac Prevention and Rehabilitation Hospital was set up at Khopoli and opening of first Madhavbaug Clinic was inaugurated at Dombivili, Maharashtra. In 2009, the company set up inhouse research and development team at Thane. In 2012, the First Cardiac Prevention and Rehabilitation Hospital was set up at Nagpur. In 2013, there was an opening of 100th Madhavbaug Clinic at Kankavli, Ratnagiri. In 2014, Arogyam Hriday Sampada launched with a Mission to create awareness of heart disease. In 2015, the company launched therapies for risk factors such as diabetes, obesity and hypertension at Madhavbaug Clinics. In 2016, there was a disease wise diet kits introduced at Madhavbaug Clinics and Madhavbaug Institute of Preventive Cardiology established with MUHS. In 2017, Madhavbaug Clinics received Frost and Sullivan`s 2017 India Best Practices Award and randomised controlled trial by Madhavbaug was published in Indian Heart Journal, Official publication of Cardiological Society of India. In 2018, Madhavbaug Clinics entered in India Book of Records for conducting GTT of 661 diabetic patients in single day at 13 different locations. It had participated as main sponsor of World Ayurved Congress 2018 held in Ahmedabad. There was an opening of 200th Madhavbaug Clinic at Nanded, Maharashtra. In 2019, Madhavbaug introduced research based heart blockage management program. It achieved new registrations of over 90,000 patients and more than 27,000 stress tests were conducted and over 3,00,000 panchkarma procedures performed. In 2020, it launched MIB Pulse Mobile Application for patient engagement. In 2021, there was an opening of 250th Madhavbaug Clinic at Vashi. Research trial on one year follow-up of diabetes patients treated by Madhavbaug was published in Journal of Association of Physicians of India. MIB Pulse Mobile Application achieved over 1,00,000 downloads. The company further launched a new Covid care plan for rehabilitation of patients who have recovered from Covid 19. it launched online portal www.madhavbaugwellness.com for new wellness products such as Madhav Shakti Atta, apple cider vinegar, prosix dosa mix, nutriboom ghavan mix, digy smooth moong daliya, lentigrain idli mix, Insta health thalli peeth, power mix muthiya aata, diapram kadha, arj kadha, groundnut oil, amla lichi syrup, etc. and many more.

Read More

Registered Address

201 B Bhoomi Velocity Road, No.23 Above ICICI Bank Thane(W, Thane, Maharashtra, 400604

Tel : 91-7738070019
Email : cs:madhavbaug.com
Website : http://www.madhavbaug.org

Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) :
Face Value Equity Shares : 10
Market Lot Equity Shares : 1600
BSE Code : 535434
NSE Code : MADHAVBAUG
Book Closure Date (Month) :
BSE Group :
ISIN : INE0JR301013

ICICIdirect Vaidya Sane Ayurved Laboratories Ltd FAQ

You can buy Vaidya Sane Ayurved Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vaidya Sane Ayurved Laboratories Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 20, 2022 03:31 PM the closing price of Vaidya Sane Ayurved Laboratories Ltd was ₹ 159.10.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 20, 2022 03:31 PM, the market cap of Vaidya Sane Ayurved Laboratories Ltd stood at ₹ 167.26.
The latest PE ratio of Vaidya Sane Ayurved Laboratories Ltd as of May 20, 2022 03:31 PM is 48.21
The latest PB ratio of Vaidya Sane Ayurved Laboratories Ltd as of May 20, 2022 03:31 PM is 0.21
The 52-week high of Vaidya Sane Ayurved Laboratories Ltd is ₹ 249.40 while the 52-week low is ₹ 98.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE